ETFs

ProQR Therapeutics (NASDAQ:PRQR) Stock Rating Upgraded ...

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by investment an...

Methanex (NASDAQ:MEOH) Cut to “Sector Perform” at Scoti...

Methanex (NASDAQ:MEOH – Get Free Report) (TSE:MX) was downgraded by analysts at ...

Orchestra BioMed’s (OBIO) “Buy” Rating Reiterated at HC...

Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating re...

Immunome’s (IMNM) “Outperform” Rating Reaffirmed at Wed...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating rei...

Bank of America Has Lowered Expectations for Merus (NAS...

Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts a...

Benchmark Reaffirms Buy Rating for Magnite (NASDAQ:MGNI)

Magnite (NASDAQ:MGNI – Get Free Report)‘s stock had its “buy” rating reaffirmed ...

Guggenheim Cuts iHeartMedia (NASDAQ:IHRT) Price Target ...

iHeartMedia (NASDAQ:IHRT – Get Free Report) had its price target reduced by equi...

Wedbush Reaffirms Outperform Rating for Inozyme Pharma ...

Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rati...

Pulmonx (NASDAQ:LUNG) Now Covered by Analysts at D. Bor...

Investment analysts at D. Boral Capital initiated coverage on shares of Pulmonx ...

4D Molecular Therapeutics (NASDAQ:FDMT) Given New $40.0...

4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target d...

Hoth Therapeutics (NASDAQ:HOTH) Given “Buy” Rating at D...

Hoth Therapeutics (NASDAQ:HOTH – Get Free Report)‘s stock had its “buy” rating r...

CareTrust REIT (NASDAQ:CTRE) Given New $31.00 Price Tar...

CareTrust REIT (NASDAQ:CTRE – Get Free Report) had its price target lowered by i...

Information Services Group (NASDAQ:III) Receives Outper...

Information Services Group (NASDAQ:III – Get Free Report)‘s stock had its “outpe...

DXP Enterprises (NASDAQ:DXPE) Price Target Raised to $9...

DXP Enterprises (NASDAQ:DXPE – Get Free Report) had its price target raised by S...

Gevo (NASDAQ:GEVO) Earns “Buy” Rating from HC Wainwright

Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by HC...

Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered ...

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price reduced...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.